Logos Global Management LP Igm Biosciences, Inc. Transaction History

Logos Global Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$71.56 - $121.23 $10.7 Million - $18.2 Million	-150,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$47.41 - $115.03 $7.11 Million - $17.3 Million	150,000 New	150,000 $13.2 Million
Q3 2020 Nov 16, 2020	SELL	$43.0 - $84.01 $3.95 Million - $7.72 Million	-91,841 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$51.3 - $75.21 $4.21 Million - $6.17 Million	-82,024 Reduced 47.18%	91,841 $6.7 Million
Q1 2020 May 15, 2020	BUY	$31.51 - $73.75 $1.87 Million - $4.38 Million	59,454 Added 51.97%	173,865 $9.76 Million
Q4 2019 Feb 14, 2020	BUY	$17.25 - $49.51 $1.97 Million - $5.66 Million	114,411 New	114,411 $4.37 Million

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $499M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.